홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
INTS
#3863
Intensity Therapeutics, Inc. Common stock
7.6
6
+4.64%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+4.64%
월간 변동
+1915.79%
6달 변화
+2541.38%
년간 변동율
+234.50%
이전 종가
7.3
2
Open
7.6
6
Bid
Ask
Low
7.6
6
High
7.6
6
양
1
마켓
주식
헬스케어
INTS
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
548.38 K
607.24 K
—
Valuation ratios
Enterprise value
-3.8 M
-1.52 M
-9.12 M
Price to earnings ratio
-0.25
-0.06
-0.17
Price to sales ratio
1.32
—
—
Price to cash flow ratio
0.41
0.06
0.18
Price to book ratio
0.23
0.34
0.47
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.61
3.41
2.6
Return on equity %
0.8
5.59
12.51
Return on invested capital %
1 797.73
4 021.82
—
Gross margin %
100
—
—
Operating margin %
367.77
—
—
EBITDA margin %
—
—
—
Net margin %
464.19
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
3.91
1.92
7.54
Inventory turnover
—
—
—
Asset turnover
0.13
0
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
20.91
27.36
12.71
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
42.94
4.67
13.2
Net current asset value per share
44.87
6.05
17.55
Tangible book value per share
38.19
5.25
12.88
Working capital per share
33.38
2.89
5.87
Book value per share
38.19
5.25
12.88
뉴스
Intensity Therapeutics, 1대 25 주식 병합 발표
Intensity Therapeutics announces 1-for-25 reverse stock split
What's Going On With Intensity Therapeutics Stock Friday? - Intensity Therapeutics (NASDAQ:INTS)
Intensity Therapeutics, 임상 검증 후 2026년 우선순위 발표
Intensity therapeutics outlines 2026 priorities after clinical validation
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Intensity Therapeutics, 나스닥 상장 연장 승인 후 주가 상승
Intensity Therapeutics stock rises after securing Nasdaq listing extension
Intensity Therapeutics, 나스닥 가격 요건 유예 180일 연장
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule
Intensity Therapeutics, ATM 프로그램 규모 3천만 달러로 확대
Intensity Therapeutics expands at-the-market offering program to $30 million